16–19 | 20–24 | 25–34 | 35–44 | Total aged 16–44 | ||||||
% | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | % | 95% CI | |
Men | ||||||||||
Denom. (unwt, wt)† | 578, 370 | 785, 620 | 1432, 1284 | 775, 1367 | 3570, 3642 | |||||
Genital warts | ||||||||||
Ever | 0.2% | (<0.1 to 0.9) | 1.8% | (1.0 to 3.3) | 4.7% | (3.6 to 6.1) | 4.9% | (3.4 to 6.8) | 3.8% | (3.0 to 4.7) |
Past 5 years | 0.2% | (<0.1 to 0.9) | 1.8% | (1.0 to 3.3) | 2.0% | (1.3 to 3.0) | 0.6% | (0.3 to 1.5) | 1.3% | (0.9 to 1.7) |
Past year | 0.2% | (<0.1 to 0.9) | 0.4% | (0.1 to 1.4) | 0.4% | (0.1 to 1.1) | 0.2% | (<0.1 to 1.3) | 0.3% | (0.2 to 0.6) |
Women | ||||||||||
Denom. (unwt, wt)† | 667, 341 | 1059, 621 | 2362, 1304 | 1169, 1397 | 5257, 3662 | |||||
Genital warts | ||||||||||
Ever | 1.5% | (0.7 to 2.9) | 5.0% | (3.6 to 7.0) | 4.8% | (3.9 to 6.0) | 4.9% | (3.8 to 6.4) | 4.6% | (4.0 to 5.3) |
Past 5 years | 1.1% | (0.6 to 2.3) | 4.3% | (2.9 to 6.3) | 1.6% | (1.1 to 2.4) | 0.6% | (0.3 to 1.3) | 1.7% | (1.3 to 2.1) |
Past year | 0.7% | (0.3 to 1.7) | 1.2% | (0.6 to 2.5) | 0.1% | (<0.1 to 0.6) | <0.1% | (<0.1 to 0.4) | 0.3% | (0.2 to 0.6) |
*Data from Natsal-3 2010–2012.
†Denominators are those with 1+partner ever.